Daewoong Pharmaceutical Co., Ltd.

Daewoong Bio Inc.

In Therapeutics

Sun Ah Jun

Jun Hee Lee

In Woo Kim

Ji Duck Kim

Hyo Shin Kim

Nam Youn Kim

Myunggi Jung

Hyung Geun Lee

Min Hee Cho

Joon Seok Park

Ha Young Kim

Sung Woo Park

Seong Cheol Moon

Soo Jin Choi

Chun Ho Lee

Mi Ryeong Han

Ja Kyung Yoo

Hyae Jung Hyun

Yun Soo Yoon

Hee Kyoon Yoon

Byung Goo Lee

Ji Sung Yoon

Yun Soo Na

Min Jae Cho

Il-Hwan Kim

Inwoo Kim

Hyung-Geun Lee

Jakyung Yoo

Yeon Jung Yoon

Yun Ju Oh

Sung-Young Kim

Kyung Ha Chung

Yoon Seok Song

The present invention relates to a compound represented by the following Chemical Formula 1, or a pharmaceutically acceptable salt, stereoisomer, or tautomer thereof, and the compound according to the present invention can be usefully used for the prevention or treatment of diseases which are associated with kinase inhibitory actions: 

Substituted piperidines as kinase inhibitors

The present invention relates to a compound represented by the Chemical Formula 1 defined in the present specification, or a pharmaceutically acceptable salt thereof. The compound according to the present invention can be usefully used for the prevention or treatment of diseases which are associated with kinase inhibitory actions. 

Substituted pyrrolo[2,1-f][1,2,4]triazines as kinase inhibitors

The present invention relates to a pyrazolopyrimidine derivative, or a pharmaceutically acceptable salt thereof. The compound according to the present invention can be usefully used for the prevention or treatment of diseases which are associated with kinase inhibitory actions.

Pyrazolopyrimidine derivatives as kinase inhibitor

The present invention relates to a compound having a blocking effect against sodium ion channels, particularly Nav1.7, a preparation method thereof and use thereof. The compound represented by the Formula 1 or a pharmaceutically acceptable salt, hydrate, solvate or isomer thereof can be effectively used in the prevention or treatment of pains, for example, acute pain, chronic pain, pain from nervous disease, postoperative pain, migraine, arthralgia, neuropathy, nerve injury, diabetic neuropathy, neuropathic disease, epilepsy, arrhythmia, myotonia, ataxia, multiple sclerosis, irritable bowel syndrome, urinary incontinence, visceral pain, depression, erythromelalgia, paroxysmal extreme pain disorder (PEPD).

Sodium channel blockers

The invention relates to a compound represented by Chemical Formula 1, below, a pharmaceutically acceptable salt thereof, and a pharmaceutical composition comprising the compound or salt. The compound of the invention or pharmaceutically acceptable salts thereof can be used for the prevention or treatment of sodium channel blocker-related diseases. 

Substituted benzenesulfonamides as sodium channel blockers

The present invention relates to a compound having a blocking effect against sodium ion channels, particularly Nav1.7, a preparation method thereof and the use thereof. A compound represented by formula 1 according to the invention, or a pharmaceutically acceptable salt, hydrate, solvate or isomer thereof may be effectively used for the prevention or treatment of pain, for example, acute pain, chronic pain, neuropathic pain, post-surgery pain, migraine, arthralgia, neuropathy, nerve injury, diabetic neuropathy, neuropathic disease, epilepsy, arrhythmia, myotonia, ataxia, multiple sclerosis, irritable bowel syndrome, urinary incontinence, visceral pain, depression, erythromelalgia, or paroxysmal extreme pain disorder (PEPD).

Sodium channel blockers, preparation method thereof and use thereof

The present invention relates to an improved method for synthesizing meropenem trihydrate[(1R,5S,6S)-2-[((2'S,4&#x2032;S)-2&#x2032;-dimethylaminocarbozyl)pyrrolidin-4&#x2032;-ylthio]-6-[(R)-1-hydroxyethyl]-1-methylcarbapen-2-em-3-carboxylic acid, trihydrate], which is a novel carbapenem antibiotic.

Method for preparing meropenem using zinc powder

Growing community of inventors

Gyeonggi-do, South Korea

Sun Ah Jun